Antibody targeting of mutant calreticulin in myeloproliferative neoplasms.

Abstract excerpt

Mutations in calreticulin are one of the key disease-initiating mutations in myeloproliferative neoplasms (MPN). In MPN, mutant calreticulin translates with a novel C-terminus that leads to aberrant binding to the extracellular domain of the thrombopoietin receptor, MPL. This cell surface neoantigen has become an attractive target for immunological intervention. Here, we summarize recent advances in the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calreticulin
• Share to Mutation
• Share to Myeloproliferative Disorders